Aspirin 68% Mortality Reduction In Coronary Bypass Patients Seen In Study
This article was originally published in The Tan Sheet
Executive Summary
Aspirin was associated with a 44%-70% reduction in major adverse events when taken within 48 hours of coronary-artery bypass surgery, according to a study in the Oct. 24 New England Journal of Medicine